Howard Levy - Chief Medical Officer at GYRE THERAPEUTICS, INC.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
GYRE on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Howard Levy since 05 Sep 2025

Reported holdings for Howard Levy in GYRE THERAPEUTICS, INC.

Form 4 holding Chief Medical Officer

CATALYST BIOSCIENCES, INC.

Security class
Common Stock
Shares / value
23,390
Estimated value
$10,993
Report date
09 Aug 2021
Price
$0.4700
Ownership
By Howard and Gillian Levy Revocable Trust dated November 21, 1994
Form 4 holding Chief Medical Officer

CATALYST BIOSCIENCES, INC.

Security class
Common Stock
Shares / value
639
Estimated value
$300
Report date
09 Aug 2021
Price
$0.4700
Ownership
Direct

Transaction history for Howard Levy in GYRE THERAPEUTICS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .